Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
fda
cannabidiol
cannabis
clinical trials
dravet syndrome
drugs
epidiolex
fen-phen
fenfluramine
government
gw pharmaceuticals
lennox-gastaut syndrome
life sciences
marijuana
medical marijuana
national blog main
san francisco
san francisco blog main
san francisco top stories
tc
zogenix
What
cannabis
drug
3
×
epilepsy
3
×
approval
approved
cbd
fda
marijuana
medicine
patients
treatment
accessibility
ago
announced
based
battle
called
chemical
compound
contains
currently
data
dea
derivative
derived
driving
epidiolex
epileptic
estimated
fast
form
gets
greenlight
gw
gw’s
huge
impact
market
medication
nationwide
Language
Current search:
epilepsy
×
drug
×
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@techcrunch.com
5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@WIRED
6 years ago
Currently, CBD is a Schedule 1 drug like cannabis, and the DEA must reschedule it before the epilepsy medication can be sold. If approved, this would have ...